Brawn Biotech Claims Exemption from SEBI RPT Disclosure Regulations
Brawn Biotech Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 9:59 pm
Brawn Biotech Claims Exemption from SEBI RPT Disclosure Regulations Brawn Biotech submitted an undertaking regarding the non-applicability of Related Party Transactions (RPT) filing under Regulation 23(9) of SEBI LODR Regulations for the quarter ended Sep'26. As of 31st Mar'26, the company reported a paid-up share capital of Rs. 3 Cr and a net worth of approximately Rs. 4.32 Cr. Both metrics have remained below the regulatory exemption thresholds of Rs. 10 Cr and Rs. 25 Cr, respectively, for the last three consecutive financial years pursuant to Regulation 15(2).
Original exchange filing (PDF)
More announcements from Brawn Biotech Ltd
- Outcome of Board Meeting 路 05 Nov 2026
- Outcome Of Board Meeting Held On 5th November, 2026 To Consider And Approve, Inter-Alia, Un-Audited Financial Results Of The Company For Quarter Ended September 30, 2026. 路 05 Nov 2026
- Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results .... 路 05 Nov 2026
- Disclosure under Regulation 30 of SEBI LODR Regulations, 2015 路 29 Sept 2026
- Scrutinizers Report attached along with voting results for 41st AGM 路 29 Sept 2026
- Proceedings of 41st AGM 路 29 Sept 2026
- Outcome of 41st Annual General Meeting 路 29 Sept 2026
- Letters sent to shareholders as per Reg 36 路 02 Sept 2026
